Compounds > ethinyl estradiol
Page last updated: 2024-08-17

ethinyl estradiol and Activated Protein C Resistance

ethinyl estradiol has been researched along with Activated Protein C Resistance in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's9 (75.00)29.6817
2010's1 (8.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Douxfils, J; Duijkers, I; Foidart, JM; Jost, M; Kinet, V; Klipping, C; Maillard, C; Mawet, M; Rosing, J1
Grande, LA; Krug, RT; Mendez, RD; Verschuyl, EJ1
Duijkers, I; Junge, W; Klipping, C; Mellinger, U; Parke, S; Serrani, M1
Algra, A; Bouma, BN; Grobbee, DE; Kemmeren, JM; Meijers, JC2
Gooren, LJ; Magdeleyns, EJ; Rosing, J; Tans, G; Thomassen, MC; Toorians, AW; Zweegman, S1
Bouma, BN; Deguchi, H; Griffin, JH; Lee, YM; Middeldorp, S1
Burggraaf, J; de Kam, ML; Kluft, C; Meijer, P; Ménard, J; Rad, M; Sitruk-Ware, RL; Sivin, I1
Bouma, BN; Büller, HR; Christella, M; Curvers, J; Meijers, JC; Middeldorp, S; Nicolaes, GA; Prins, MH; Rosing, J; Tans, G; Thomassen, LG1
Kluft, C1
Bouma, BN; Büller, HR; Curvers, J; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Thomassen, MC1
Bannemerschult, R; Düsterberg, B; Endrikat, J; Gerlinger, C; Junge, W; Noah, M; Ruebig, A; Schmidt, W1

Trials

9 trial(s) available for ethinyl estradiol and Activated Protein C Resistance

ArticleYear
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
    Contraception, 2020, Volume: 102, Issue:6

    Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Menstrual Cycle; Middle Aged; Sex Hormone-Binding Globulin; Young Adult

2020
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
    Drugs in R&D, 2011, Volume: 11, Issue:2

    Topics: Activated Protein C Resistance; Adolescent; Adult; Antigens; Antithrombin III; Blood Pressure; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Estradiol; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Levonorgestrel; Middle Aged; Nandrolone; Patient Compliance; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Sex Hormone-Binding Globulin; Young Adult

2011
Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:5

    Topics: Activated Protein C Resistance; Adult; Carboxypeptidase B2; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Thrombophilia

2002
Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:5

    Topics: Activated Protein C Resistance; Chromatography, High Pressure Liquid; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Glucosylceramides; Humans; Levonorgestrel; Pilot Projects; Protein C; Protein S; Prothrombin Time; Risk; Sensitivity and Specificity; Venous Thrombosis

2005
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.
    American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:1

    Topics: Activated Protein C Resistance; Adolescent; Adult; Blood Coagulation Factors; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrinolysis; Humans; Immunoradiometric Assay; Norprogesterones; Plasminogen; Protein C; Sex Hormone-Binding Globulin

2006
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Lancet (London, England), 1999, Dec-11, Volume: 354, Issue:9195

    Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein C; Risk Factors; Thrombin; Thromboembolism

1999
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:1

    Topics: Activated Protein C Resistance; Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Biomarkers; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Netherlands; Partial Thromboplastin Time; Protein C; Protein C Inhibitor; Protein S; Thrombin; Thrombophilia

2000
Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations.
    Contraception, 2001, Volume: 64, Issue:4

    Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Factor V; Female; Humans; Mutation; Norethindrone; Polymerase Chain Reaction; Prospective Studies; Protein C; Venous Thrombosis

2001
Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Thrombosis and haemostasis, 2002, Volume: 87, Issue:2

    Topics: Activated Protein C Resistance; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor IX; Factor V; Factor VII; Female; Humans; Levonorgestrel; Peptide Fragments; Prothrombin; Thrombophilia

2002

Other Studies

3 other study(ies) available for ethinyl estradiol and Activated Protein C Resistance

ArticleYear
Attention--grapefruit!
    Lancet (London, England), 2009, Apr-04, Volume: 373, Issue:9670

    Topics: Activated Protein C Resistance; Adult; Automobile Driving; Beverages; Biological Availability; Citrus paradisi; Constriction, Pathologic; Contraceptives, Oral, Hormonal; Emergency Treatment; Ethinyl Estradiol; Factor V; Female; Humans; Iliac Vein; Mutation; Risk Factors; Stents; Thrombolytic Therapy; Venous Thrombosis

2009
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:12

    Topics: Activated Protein C Resistance; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hemostasis; Hormones; Humans; Male; Sex Characteristics; Testosterone; Transsexualism; Venous Thrombosis

2003
Renewed interest in haemostasis changes induced by oral contraceptives (OCs)
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:1

    Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Genetic Predisposition to Disease; Hemostasis; Humans; Levonorgestrel; Partial Thromboplastin Time; Randomized Controlled Trials as Topic; Thrombophilia; Venous Thrombosis

2000